nodes	percent_of_prediction	percent_of_DWPC	metapath
Pralatrexate—Cardio-respiratory arrest—Aminophylline—chronic obstructive pulmonary disease	0.0336	0.0655	CcSEcCtD
Pralatrexate—FPGS—respiratory system—chronic obstructive pulmonary disease	0.028	0.1	CbGeAlD
Pralatrexate—FPGS—connective tissue—chronic obstructive pulmonary disease	0.0246	0.088	CbGeAlD
Pralatrexate—FPGS—bronchus—chronic obstructive pulmonary disease	0.023	0.0823	CbGeAlD
Pralatrexate—SLC19A1—lung—chronic obstructive pulmonary disease	0.0223	0.0797	CbGeAlD
Pralatrexate—FPGS—trachea—chronic obstructive pulmonary disease	0.0207	0.0739	CbGeAlD
Pralatrexate—SLC19A1—Folate Metabolism—SOD3—chronic obstructive pulmonary disease	0.0191	0.102	CbGpPWpGaD
Pralatrexate—TYMS—respiratory system—chronic obstructive pulmonary disease	0.0183	0.0656	CbGeAlD
Pralatrexate—DHFR—respiratory system—chronic obstructive pulmonary disease	0.0182	0.0649	CbGeAlD
Pralatrexate—Pharyngolaryngeal pain—Tiotropium—chronic obstructive pulmonary disease	0.0168	0.0327	CcSEcCtD
Pralatrexate—Laryngeal pain—Tiotropium—chronic obstructive pulmonary disease	0.0166	0.0324	CcSEcCtD
Pralatrexate—TYMS—connective tissue—chronic obstructive pulmonary disease	0.0161	0.0577	CbGeAlD
Pralatrexate—DHFR—connective tissue—chronic obstructive pulmonary disease	0.016	0.0572	CbGeAlD
Pralatrexate—TYMS—bronchus—chronic obstructive pulmonary disease	0.0151	0.054	CbGeAlD
Pralatrexate—DHFR—bronchus—chronic obstructive pulmonary disease	0.0149	0.0534	CbGeAlD
Pralatrexate—FPGS—lung—chronic obstructive pulmonary disease	0.0148	0.0531	CbGeAlD
Pralatrexate—TYMS—smooth muscle tissue—chronic obstructive pulmonary disease	0.0148	0.0528	CbGeAlD
Pralatrexate—DHFR—trachea—chronic obstructive pulmonary disease	0.0134	0.048	CbGeAlD
Pralatrexate—SLC19A1—Folate Metabolism—MPO—chronic obstructive pulmonary disease	0.0129	0.0682	CbGpPWpGaD
Pralatrexate—TYMS—lung—chronic obstructive pulmonary disease	0.00974	0.0348	CbGeAlD
Pralatrexate—DHFR—lung—chronic obstructive pulmonary disease	0.00964	0.0345	CbGeAlD
Pralatrexate—Pain in extremity—Tiotropium—chronic obstructive pulmonary disease	0.00822	0.016	CcSEcCtD
Pralatrexate—Hypokalaemia—Aminophylline—chronic obstructive pulmonary disease	0.00793	0.0155	CcSEcCtD
Pralatrexate—DHFR—Trans-sulfuration and one carbon metabolism—GCLC—chronic obstructive pulmonary disease	0.00791	0.042	CbGpPWpGaD
Pralatrexate—Dehydration—Tiotropium—chronic obstructive pulmonary disease	0.00764	0.0149	CcSEcCtD
Pralatrexate—Back pain—Roflumilast—chronic obstructive pulmonary disease	0.00761	0.0148	CcSEcCtD
Pralatrexate—TYMS—Trans-sulfuration and one carbon metabolism—GCLC—chronic obstructive pulmonary disease	0.0069	0.0366	CbGpPWpGaD
Pralatrexate—DHFR—Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation—NOS3—chronic obstructive pulmonary disease	0.00688	0.0365	CbGpPWpGaD
Pralatrexate—DHFR—Folate Metabolism—SOD3—chronic obstructive pulmonary disease	0.0068	0.0361	CbGpPWpGaD
Pralatrexate—SLC19A1—Folate Metabolism—CRP—chronic obstructive pulmonary disease	0.00676	0.0359	CbGpPWpGaD
Pralatrexate—Upper respiratory tract infection—Tiotropium—chronic obstructive pulmonary disease	0.0066	0.0129	CcSEcCtD
Pralatrexate—Dehydration—Formoterol—chronic obstructive pulmonary disease	0.00617	0.012	CcSEcCtD
Pralatrexate—Dehydration—Arformoterol—chronic obstructive pulmonary disease	0.00617	0.012	CcSEcCtD
Pralatrexate—Hypokalaemia—Arformoterol—chronic obstructive pulmonary disease	0.00603	0.0118	CcSEcCtD
Pralatrexate—Hypokalaemia—Formoterol—chronic obstructive pulmonary disease	0.00603	0.0118	CcSEcCtD
Pralatrexate—Epistaxis—Tiotropium—chronic obstructive pulmonary disease	0.00597	0.0116	CcSEcCtD
Pralatrexate—Toxic epidermal necrolysis—Montelukast—chronic obstructive pulmonary disease	0.00585	0.0114	CcSEcCtD
Pralatrexate—Hypokalaemia—Salbutamol—chronic obstructive pulmonary disease	0.0057	0.0111	CcSEcCtD
Pralatrexate—Decreased appetite—Roflumilast—chronic obstructive pulmonary disease	0.00558	0.0109	CcSEcCtD
Pralatrexate—Fatigue—Roflumilast—chronic obstructive pulmonary disease	0.00554	0.0108	CcSEcCtD
Pralatrexate—Constipation—Roflumilast—chronic obstructive pulmonary disease	0.00549	0.0107	CcSEcCtD
Pralatrexate—Upper respiratory tract infection—Formoterol—chronic obstructive pulmonary disease	0.00533	0.0104	CcSEcCtD
Pralatrexate—Upper respiratory tract infection—Arformoterol—chronic obstructive pulmonary disease	0.00533	0.0104	CcSEcCtD
Pralatrexate—Gastrointestinal pain—Roflumilast—chronic obstructive pulmonary disease	0.00525	0.0102	CcSEcCtD
Pralatrexate—Upper respiratory tract infection—Montelukast—chronic obstructive pulmonary disease	0.00522	0.0102	CcSEcCtD
Pralatrexate—SLC19A1—Folate Metabolism—SERPINE1—chronic obstructive pulmonary disease	0.00519	0.0275	CbGpPWpGaD
Pralatrexate—SLC19A1—Folate Metabolism—ALB—chronic obstructive pulmonary disease	0.00518	0.0275	CbGpPWpGaD
Pralatrexate—Abdominal pain—Roflumilast—chronic obstructive pulmonary disease	0.00508	0.0099	CcSEcCtD
Pralatrexate—Upper respiratory tract infection—Salbutamol—chronic obstructive pulmonary disease	0.00503	0.00981	CcSEcCtD
Pralatrexate—Back pain—Tiotropium—chronic obstructive pulmonary disease	0.00479	0.00933	CcSEcCtD
Pralatrexate—DHFR—Metabolism of nitric oxide—NOS3—chronic obstructive pulmonary disease	0.00477	0.0253	CbGpPWpGaD
Pralatrexate—Epistaxis—Montelukast—chronic obstructive pulmonary disease	0.00472	0.0092	CcSEcCtD
Pralatrexate—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.00461	0.00898	CcSEcCtD
Pralatrexate—DHFR—Folate Metabolism—MPO—chronic obstructive pulmonary disease	0.00457	0.0242	CbGpPWpGaD
Pralatrexate—Epistaxis—Salbutamol—chronic obstructive pulmonary disease	0.00455	0.00887	CcSEcCtD
Pralatrexate—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.00439	0.00857	CcSEcCtD
Pralatrexate—Cough—Tiotropium—chronic obstructive pulmonary disease	0.00432	0.00842	CcSEcCtD
Pralatrexate—SLC19A1—Folate Metabolism—IL1B—chronic obstructive pulmonary disease	0.00422	0.0224	CbGpPWpGaD
Pralatrexate—Tachycardia—Aminophylline—chronic obstructive pulmonary disease	0.00418	0.00815	CcSEcCtD
Pralatrexate—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.00408	0.00796	CcSEcCtD
Pralatrexate—Anorexia—Aminophylline—chronic obstructive pulmonary disease	0.00408	0.00796	CcSEcCtD
Pralatrexate—Rash—Roflumilast—chronic obstructive pulmonary disease	0.00405	0.00789	CcSEcCtD
Pralatrexate—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.00405	0.00789	CcSEcCtD
Pralatrexate—Oedema—Tiotropium—chronic obstructive pulmonary disease	0.00404	0.00787	CcSEcCtD
Pralatrexate—FPGS—Fluoropyrimidine Activity—TP53—chronic obstructive pulmonary disease	0.00399	0.0212	CbGpPWpGaD
Pralatrexate—Tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.00394	0.00768	CcSEcCtD
Pralatrexate—Back pain—Formoterol—chronic obstructive pulmonary disease	0.00386	0.00753	CcSEcCtD
Pralatrexate—Back pain—Arformoterol—chronic obstructive pulmonary disease	0.00386	0.00753	CcSEcCtD
Pralatrexate—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00381	0.00744	CcSEcCtD
Pralatrexate—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.00372	0.00726	CcSEcCtD
Pralatrexate—Back pain—Salbutamol—chronic obstructive pulmonary disease	0.00365	0.00711	CcSEcCtD
Pralatrexate—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.0035	0.00683	CcSEcCtD
Pralatrexate—Cough—Arformoterol—chronic obstructive pulmonary disease	0.00348	0.00679	CcSEcCtD
Pralatrexate—Cough—Formoterol—chronic obstructive pulmonary disease	0.00348	0.00679	CcSEcCtD
Pralatrexate—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.00345	0.00673	CcSEcCtD
Pralatrexate—Cough—Montelukast—chronic obstructive pulmonary disease	0.00341	0.00665	CcSEcCtD
Pralatrexate—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.00339	0.0066	CcSEcCtD
Pralatrexate—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.00339	0.0066	CcSEcCtD
Pralatrexate—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.0033	0.00644	CcSEcCtD
Pralatrexate—Cough—Salbutamol—chronic obstructive pulmonary disease	0.00329	0.00642	CcSEcCtD
Pralatrexate—Oedema—Formoterol—chronic obstructive pulmonary disease	0.00326	0.00635	CcSEcCtD
Pralatrexate—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.00326	0.00635	CcSEcCtD
Pralatrexate—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.00319	0.00622	CcSEcCtD
Pralatrexate—Oedema—Montelukast—chronic obstructive pulmonary disease	0.00319	0.00622	CcSEcCtD
Pralatrexate—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.00318	0.0062	CcSEcCtD
Pralatrexate—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.00318	0.0062	CcSEcCtD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—RAPGEF3—chronic obstructive pulmonary disease	0.00315	0.0167	CbGpPWpGaD
Pralatrexate—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.00313	0.00609	CcSEcCtD
Pralatrexate—Sepsis—Prednisone—chronic obstructive pulmonary disease	0.00312	0.00608	CcSEcCtD
Pralatrexate—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.00308	0.006	CcSEcCtD
Pralatrexate—SLC19A1—Folate Metabolism—TNF—chronic obstructive pulmonary disease	0.00306	0.0162	CbGpPWpGaD
Pralatrexate—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.00303	0.00591	CcSEcCtD
Pralatrexate—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.003	0.00586	CcSEcCtD
Pralatrexate—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.00293	0.00572	CcSEcCtD
Pralatrexate—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.00293	0.00571	CcSEcCtD
Pralatrexate—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.00291	0.00566	CcSEcCtD
Pralatrexate—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.00291	0.00566	CcSEcCtD
Pralatrexate—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.00286	0.00557	CcSEcCtD
Pralatrexate—SLC19A1—Metabolism—APIP—chronic obstructive pulmonary disease	0.00285	0.0151	CbGpPWpGaD
Pralatrexate—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.00281	0.00548	CcSEcCtD
Pralatrexate—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.00281	0.00548	CcSEcCtD
Pralatrexate—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.00279	0.00543	CcSEcCtD
Pralatrexate—Constipation—Formoterol—chronic obstructive pulmonary disease	0.00279	0.00543	CcSEcCtD
Pralatrexate—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.00275	0.00537	CcSEcCtD
Pralatrexate—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.00274	0.00535	CcSEcCtD
Pralatrexate—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.00272	0.00531	CcSEcCtD
Pralatrexate—Rash—Aminophylline—chronic obstructive pulmonary disease	0.0027	0.00526	CcSEcCtD
Pralatrexate—SLC19A1—Folate Metabolism—TP53—chronic obstructive pulmonary disease	0.0027	0.0143	CbGpPWpGaD
Pralatrexate—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.0027	0.00526	CcSEcCtD
Pralatrexate—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.00268	0.00522	CcSEcCtD
Pralatrexate—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.00266	0.0052	CcSEcCtD
Pralatrexate—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.00266	0.0052	CcSEcCtD
Pralatrexate—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.00265	0.00517	CcSEcCtD
Pralatrexate—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.00263	0.00513	CcSEcCtD
Pralatrexate—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.00261	0.00509	CcSEcCtD
Pralatrexate—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.00258	0.00502	CcSEcCtD
Pralatrexate—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.00258	0.00502	CcSEcCtD
Pralatrexate—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.00258	0.00502	CcSEcCtD
Pralatrexate—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.00258	0.00502	CcSEcCtD
Pralatrexate—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.00257	0.00501	CcSEcCtD
Pralatrexate—Rash—Tiotropium—chronic obstructive pulmonary disease	0.00255	0.00496	CcSEcCtD
Pralatrexate—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.00254	0.00496	CcSEcCtD
Pralatrexate—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.00254	0.00496	CcSEcCtD
Pralatrexate—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.00252	0.00492	CcSEcCtD
Pralatrexate—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.00252	0.00492	CcSEcCtD
Pralatrexate—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.00252	0.00491	CcSEcCtD
Pralatrexate—SLC19A1—Folate Metabolism—IL6—chronic obstructive pulmonary disease	0.00247	0.0131	CbGpPWpGaD
Pralatrexate—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.00243	0.00474	CcSEcCtD
Pralatrexate—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.00243	0.00474	CcSEcCtD
Pralatrexate—FPGS—Metabolism—APIP—chronic obstructive pulmonary disease	0.00242	0.0129	CbGpPWpGaD
Pralatrexate—DHFR—Folate Metabolism—CRP—chronic obstructive pulmonary disease	0.0024	0.0127	CbGpPWpGaD
Pralatrexate—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.0024	0.00468	CcSEcCtD
Pralatrexate—Hypokalaemia—Prednisone—chronic obstructive pulmonary disease	0.00237	0.00463	CcSEcCtD
Pralatrexate—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.00234	0.00456	CcSEcCtD
Pralatrexate—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.00234	0.00456	CcSEcCtD
Pralatrexate—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.00231	0.0045	CcSEcCtD
Pralatrexate—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.00231	0.0045	CcSEcCtD
Pralatrexate—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.00229	0.00447	CcSEcCtD
Pralatrexate—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.00226	0.0044	CcSEcCtD
Pralatrexate—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.00223	0.00435	CcSEcCtD
Pralatrexate—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.00223	0.00435	CcSEcCtD
Pralatrexate—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.00221	0.0043	CcSEcCtD
Pralatrexate—DHFR—E2F transcription factor network—PLAU—chronic obstructive pulmonary disease	0.0022	0.0117	CbGpPWpGaD
Pralatrexate—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.00218	0.00426	CcSEcCtD
Pralatrexate—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.00218	0.00424	CcSEcCtD
Pralatrexate—Neutropenia—Prednisone—chronic obstructive pulmonary disease	0.00211	0.00411	CcSEcCtD
Pralatrexate—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.00211	0.00411	CcSEcCtD
Pralatrexate—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.00207	0.00404	CcSEcCtD
Pralatrexate—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.00207	0.00404	CcSEcCtD
Pralatrexate—Rash—Formoterol—chronic obstructive pulmonary disease	0.00205	0.00401	CcSEcCtD
Pralatrexate—Rash—Arformoterol—chronic obstructive pulmonary disease	0.00205	0.00401	CcSEcCtD
Pralatrexate—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.00205	0.004	CcSEcCtD
Pralatrexate—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.00205	0.004	CcSEcCtD
Pralatrexate—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.00203	0.00396	CcSEcCtD
Pralatrexate—Rash—Montelukast—chronic obstructive pulmonary disease	0.00201	0.00392	CcSEcCtD
Pralatrexate—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.00201	0.00392	CcSEcCtD
Pralatrexate—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.00196	0.00381	CcSEcCtD
Pralatrexate—Rash—Salbutamol—chronic obstructive pulmonary disease	0.00194	0.00378	CcSEcCtD
Pralatrexate—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.00194	0.00378	CcSEcCtD
Pralatrexate—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.00194	0.00377	CcSEcCtD
Pralatrexate—Nausea—Formoterol—chronic obstructive pulmonary disease	0.00194	0.00377	CcSEcCtD
Pralatrexate—TYMS—E2F transcription factor network—PLAU—chronic obstructive pulmonary disease	0.00192	0.0102	CbGpPWpGaD
Pralatrexate—TYMS—Clobetasol propionate—Prednisone—chronic obstructive pulmonary disease	0.00191	0.1	CbGdCrCtD
Pralatrexate—Nausea—Montelukast—chronic obstructive pulmonary disease	0.0019	0.0037	CcSEcCtD
Pralatrexate—TYMS—Flunisolide—Prednisone—chronic obstructive pulmonary disease	0.00189	0.0992	CbGdCrCtD
Pralatrexate—SLC19A1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.00189	0.01	CbGpPWpGaD
Pralatrexate—TYMS—Triamcinolone—Prednisone—chronic obstructive pulmonary disease	0.00187	0.0982	CbGdCrCtD
Pralatrexate—TYMS—Clobetasol propionate—Prednisolone—chronic obstructive pulmonary disease	0.00187	0.0981	CbGdCrCtD
Pralatrexate—DHFR—Folate Metabolism—SERPINE1—chronic obstructive pulmonary disease	0.00184	0.00978	CbGpPWpGaD
Pralatrexate—TYMS—Flunisolide—Prednisolone—chronic obstructive pulmonary disease	0.00184	0.0968	CbGdCrCtD
Pralatrexate—DHFR—Folate Metabolism—ALB—chronic obstructive pulmonary disease	0.00184	0.00977	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—GC—chronic obstructive pulmonary disease	0.00184	0.00975	CbGpPWpGaD
Pralatrexate—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.00183	0.00356	CcSEcCtD
Pralatrexate—TYMS—Triamcinolone—Prednisolone—chronic obstructive pulmonary disease	0.00182	0.0958	CbGdCrCtD
Pralatrexate—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.00177	0.00344	CcSEcCtD
Pralatrexate—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.00172	0.00336	CcSEcCtD
Pralatrexate—TYMS—Diflorasone—Prednisone—chronic obstructive pulmonary disease	0.00172	0.0905	CbGdCrCtD
Pralatrexate—SLC19A1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.00171	0.00906	CbGpPWpGaD
Pralatrexate—DHFR—E2F transcription factor network—SERPINE1—chronic obstructive pulmonary disease	0.0017	0.00903	CbGpPWpGaD
Pralatrexate—TYMS—Diflorasone—Prednisolone—chronic obstructive pulmonary disease	0.00168	0.0883	CbGdCrCtD
Pralatrexate—DHFR—Fluoropyrimidine Activity—TP53—chronic obstructive pulmonary disease	0.00167	0.00885	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.00161	0.00852	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—GC—chronic obstructive pulmonary disease	0.00156	0.00829	CbGpPWpGaD
Pralatrexate—TYMS—Budesonide—Prednisone—chronic obstructive pulmonary disease	0.00151	0.0793	CbGdCrCtD
Pralatrexate—DHFR—Folate Metabolism—IL1B—chronic obstructive pulmonary disease	0.0015	0.00795	CbGpPWpGaD
Pralatrexate—TYMS—E2F transcription factor network—SERPINE1—chronic obstructive pulmonary disease	0.00148	0.00788	CbGpPWpGaD
Pralatrexate—TYMS—Circadian rythm related genes—SLC6A4—chronic obstructive pulmonary disease	0.00147	0.00783	CbGpPWpGaD
Pralatrexate—TYMS—Budesonide—Prednisolone—chronic obstructive pulmonary disease	0.00147	0.0774	CbGdCrCtD
Pralatrexate—TYMS—Fluoropyrimidine Activity—TP53—chronic obstructive pulmonary disease	0.00146	0.00773	CbGpPWpGaD
Pralatrexate—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.00145	0.00283	CcSEcCtD
Pralatrexate—FPGS—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.00145	0.0077	CbGpPWpGaD
Pralatrexate—TYMS—Danazol—Prednisone—chronic obstructive pulmonary disease	0.00145	0.076	CbGdCrCtD
Pralatrexate—TYMS—Circadian rythm related genes—ADIPOQ—chronic obstructive pulmonary disease	0.00135	0.00719	CbGpPWpGaD
Pralatrexate—TYMS—Circadian rythm related genes—HDAC2—chronic obstructive pulmonary disease	0.00135	0.00716	CbGpPWpGaD
Pralatrexate—Oedema—Prednisone—chronic obstructive pulmonary disease	0.00128	0.0025	CcSEcCtD
Pralatrexate—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.00125	0.00244	CcSEcCtD
Pralatrexate—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.00122	0.00238	CcSEcCtD
Pralatrexate—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.00111	0.00217	CcSEcCtD
Pralatrexate—Rash—Prednisolone—chronic obstructive pulmonary disease	0.00111	0.00217	CcSEcCtD
Pralatrexate—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.00111	0.00217	CcSEcCtD
Pralatrexate—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.00111	0.00216	CcSEcCtD
Pralatrexate—Constipation—Prednisone—chronic obstructive pulmonary disease	0.0011	0.00214	CcSEcCtD
Pralatrexate—DHFR—Folate Metabolism—TNF—chronic obstructive pulmonary disease	0.00109	0.00577	CbGpPWpGaD
Pralatrexate—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.00105	0.00204	CcSEcCtD
Pralatrexate—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.00105	0.00204	CcSEcCtD
Pralatrexate—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.00101	0.00198	CcSEcCtD
Pralatrexate—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.00101	0.00198	CcSEcCtD
Pralatrexate—DHFR—Metabolism—APIP—chronic obstructive pulmonary disease	0.00101	0.00537	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—HDAC2—chronic obstructive pulmonary disease	0.00101	0.00534	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.001	0.00532	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000992	0.00526	CbGpPWpGaD
Pralatrexate—DHFR—Folate Metabolism—TP53—chronic obstructive pulmonary disease	0.000958	0.00509	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—KL—chronic obstructive pulmonary disease	0.000936	0.00497	CbGpPWpGaD
Pralatrexate—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.00092	0.00179	CcSEcCtD
Pralatrexate—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000907	0.00177	CcSEcCtD
Pralatrexate—SLC19A1—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000905	0.0048	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—APIP—chronic obstructive pulmonary disease	0.000883	0.00469	CbGpPWpGaD
Pralatrexate—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000878	0.00171	CcSEcCtD
Pralatrexate—DHFR—Folate Metabolism—IL6—chronic obstructive pulmonary disease	0.000877	0.00465	CbGpPWpGaD
Pralatrexate—FPGS—Disease—HDAC2—chronic obstructive pulmonary disease	0.000856	0.00454	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000853	0.00453	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000843	0.00447	CbGpPWpGaD
Pralatrexate—TYMS—Circadian rythm related genes—LEP—chronic obstructive pulmonary disease	0.000841	0.00446	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000834	0.00442	CbGpPWpGaD
Pralatrexate—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000815	0.00159	CcSEcCtD
Pralatrexate—Rash—Prednisone—chronic obstructive pulmonary disease	0.000809	0.00158	CcSEcCtD
Pralatrexate—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000808	0.00158	CcSEcCtD
Pralatrexate—FPGS—Disease—KL—chronic obstructive pulmonary disease	0.000796	0.00422	CbGpPWpGaD
Pralatrexate—TYMS—Circadian rythm related genes—NOS2—chronic obstructive pulmonary disease	0.000784	0.00416	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000769	0.00408	CbGpPWpGaD
Pralatrexate—DHFR—Retinoblastoma (RB) in Cancer—TP53—chronic obstructive pulmonary disease	0.000768	0.00408	CbGpPWpGaD
Pralatrexate—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000762	0.00149	CcSEcCtD
Pralatrexate—FPGS—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000709	0.00376	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—ERBB3—chronic obstructive pulmonary disease	0.000702	0.00372	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000695	0.00369	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000686	0.00364	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000671	0.00356	CbGpPWpGaD
Pralatrexate—TYMS—Retinoblastoma (RB) in Cancer—TP53—chronic obstructive pulmonary disease	0.00067	0.00356	CbGpPWpGaD
Pralatrexate—TYMS—Circadian rythm related genes—SERPINE1—chronic obstructive pulmonary disease	0.00066	0.0035	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—GC—chronic obstructive pulmonary disease	0.000652	0.00346	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000639	0.00339	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000606	0.00322	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000606	0.00321	CbGpPWpGaD
Pralatrexate—FPGS—Disease—ERBB3—chronic obstructive pulmonary disease	0.000597	0.00317	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000591	0.00314	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000585	0.0031	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—NOS2—chronic obstructive pulmonary disease	0.000585	0.0031	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000583	0.00309	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—GC—chronic obstructive pulmonary disease	0.000569	0.00302	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000543	0.00288	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000529	0.00281	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000515	0.00273	CbGpPWpGaD
Pralatrexate—FPGS—Disease—NOS2—chronic obstructive pulmonary disease	0.000497	0.00264	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—SERPINE1—chronic obstructive pulmonary disease	0.000493	0.00261	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	0.000473	0.00251	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—NOS3—chronic obstructive pulmonary disease	0.00047	0.0025	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	0.000434	0.0023	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	0.000426	0.00226	CbGpPWpGaD
Pralatrexate—FPGS—Disease—SERPINE1—chronic obstructive pulmonary disease	0.000419	0.00222	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—ALB—chronic obstructive pulmonary disease	0.000412	0.00219	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	0.000405	0.00215	CbGpPWpGaD
Pralatrexate—FPGS—Disease—NOS3—chronic obstructive pulmonary disease	0.0004	0.00212	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—NOS3—chronic obstructive pulmonary disease	0.000394	0.00209	CbGpPWpGaD
Pralatrexate—DHFR—Disease—HDAC2—chronic obstructive pulmonary disease	0.000358	0.0019	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	0.000357	0.0019	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000356	0.00189	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000352	0.00187	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—ALB—chronic obstructive pulmonary disease	0.00035	0.00186	CbGpPWpGaD
Pralatrexate—TYMS—Circadian rythm related genes—TP53—chronic obstructive pulmonary disease	0.000343	0.00182	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—NOS3—chronic obstructive pulmonary disease	0.000335	0.00178	CbGpPWpGaD
Pralatrexate—DHFR—Disease—KL—chronic obstructive pulmonary disease	0.000332	0.00176	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000321	0.00171	CbGpPWpGaD
Pralatrexate—TYMS—Circadian rythm related genes—IL6—chronic obstructive pulmonary disease	0.000314	0.00167	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—TGFB1—chronic obstructive pulmonary disease	0.000311	0.00165	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000311	0.00165	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000307	0.00163	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—EGFR—chronic obstructive pulmonary disease	0.000305	0.00162	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000296	0.00157	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—CTGF—chronic obstructive pulmonary disease	0.00028	0.00149	CbGpPWpGaD
Pralatrexate—FPGS—Disease—TGFB1—chronic obstructive pulmonary disease	0.000264	0.0014	CbGpPWpGaD
Pralatrexate—FPGS—Disease—EGFR—chronic obstructive pulmonary disease	0.000259	0.00138	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000258	0.00137	CbGpPWpGaD
Pralatrexate—DHFR—Disease—ERBB3—chronic obstructive pulmonary disease	0.000249	0.00132	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000247	0.00131	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000244	0.00129	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—IL6—chronic obstructive pulmonary disease	0.000234	0.00124	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000227	0.0012	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000216	0.00114	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000215	0.00114	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000213	0.00113	CbGpPWpGaD
Pralatrexate—DHFR—Disease—NOS2—chronic obstructive pulmonary disease	0.000208	0.0011	CbGpPWpGaD
Pralatrexate—FPGS—Disease—IL6—chronic obstructive pulmonary disease	0.000199	0.00106	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000198	0.00105	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000188	0.000996	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—TP53—chronic obstructive pulmonary disease	0.000177	0.000941	CbGpPWpGaD
Pralatrexate—DHFR—Disease—SERPINE1—chronic obstructive pulmonary disease	0.000175	0.000929	CbGpPWpGaD
Pralatrexate—DHFR—Disease—NOS3—chronic obstructive pulmonary disease	0.000167	0.000887	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—TP53—chronic obstructive pulmonary disease	0.000155	0.000821	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—ALB—chronic obstructive pulmonary disease	0.000146	0.000776	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—NOS3—chronic obstructive pulmonary disease	0.00014	0.000742	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—ALB—chronic obstructive pulmonary disease	0.000128	0.000677	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—NOS3—chronic obstructive pulmonary disease	0.000122	0.000648	CbGpPWpGaD
Pralatrexate—DHFR—Disease—TGFB1—chronic obstructive pulmonary disease	0.00011	0.000586	CbGpPWpGaD
Pralatrexate—DHFR—Disease—EGFR—chronic obstructive pulmonary disease	0.000108	0.000575	CbGpPWpGaD
Pralatrexate—DHFR—Disease—IL6—chronic obstructive pulmonary disease	8.32e-05	0.000442	CbGpPWpGaD
